Hence, our new data demonstrates it will be necessary to hunt for further investigation to fully understand the relationship between EPLIN and its established interacting partners in pancreatic cancer, given the opposite role it has in this cancer type. The gene discussed is LIMA1; the disease is familial pancreatic carcinoma.